Discovery of Precision Oncology Drugs

NTRC provides in vitro drug discovery services focused on Precision Medicine. We help you to find the informed route to the clinic. Information can be found at www.oncolines.com

Comparative cancer cell panel profiling of kinase inhibitors

The poster presents the biochemical and cellular profiling of newly-approved kinase inhibitors and other inhibitors which act on the same target. The compounds are compared side by side based on their selectivity and potency on primary and secondary targets.